Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Milan_Stock_Exchange
gptkb:Borsa_Italiana |
| gptkbp:acquisition |
Eurand (2013)
Orphan Europe (2011) |
| gptkbp:employees |
approximately 4,000
|
| gptkbp:focus |
rare diseases
specialty pharmaceuticals |
| gptkbp:founded |
1926
|
| gptkbp:founder |
Marcello Recordati
|
| gptkbp:headquarters |
gptkb:Milan,_Italy
|
| https://www.w3.org/2000/01/rdf-schema#label |
Recordati
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:market |
gptkb:Europe
gptkb:Asia gptkb:Latin_America gptkb:North_America |
| gptkbp:products |
medicines
|
| gptkbp:revenue |
€1.5 billion (2020)
|
| gptkbp:services |
healthcare
|
| gptkbp:subsidiary |
Recordati S.p. A.
|
| gptkbp:symbol |
REC
|